Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Dual effects of arsenic trioxide (As2O3) on non‐acute promyelocytic leukaemia myeloid cell lines: induction of apoptosis and inhibition of proliferation

1 Mar 2002

Abstract excerpt

Clinical efficacy of As2O3 has been shown in patients with relapsed acute promyelocytic leukaemia (APL). There is evidence that the effects of As2O3 are not restricted to events specific for APL. As2O3 might target mechanisms involved in the pathogenesis of other malignancies. We assessed susceptibility to induction of apoptosis by As2O3 and cytostatics in 22 myeloid and non-myeloid malignant cell lines. As2O3...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acne and Rosacea Treatments and Effects
Share to Antioxidant Activity and Oxidative Stress
Share to Retinoids in leukemia and cellular processes

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 11849211
DOI: 10.1046/j.0007-1048.2001.03298.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Dual effects of arsenic trioxide (As2O3) on non‐acute promyelocytic leukaemia myeloid cell lines: induction of apoptosis and inhibition of proliferationPMID 11849211Read ↗

Molecular Targets of Arsenic Trioxide in Malignant CellsSemantic proximity Read ↗

In vitro studies on cellular and molecular mechanisms of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia: As2O3 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML-RAR alpha/PML proteinsSemantic proximity Read ↗

Arsenic trioxide-induced apoptosis and differentiation are associated respectively with mitochondrial transmembrane potential collapse and retinoic acid signaling pathways in acute promyelocytic leukemia.Semantic proximity Read ↗

Effect of Ferroptosis Inducers and Inhibitors on Cell Proliferation in Acute LeukemiaSemantic proximity Read ↗

Phase II Study of Single-Agent Arsenic Trioxide for the Front-Line Therapy of Acute Promyelocytic LeukemiaSemantic proximity Read ↗

Arsenic trioxide concentration determines the fate of Ewing's sarcoma family tumors and neuroblastoma cells in vitro.Semantic proximity Read ↗

Arsenic-Based Antineoplastic Drugs and Their Mechanisms of ActionSemantic proximity Read ↗

Treatment of acute promyelocytic leukaemia with <i>all-trans</i> retinoic acid and arsenic trioxide: a paradigm of synergistic molecular targeting therapySemantic proximity Read ↗

Retinoic acid and arsenic trioxide in the treatment of acute promyelocytic leukemia: current perspectivesSemantic proximity Read ↗

Use of arsenic trioxide (As2O3) in the treatment of patients with acute promyelocytic leukemiaSemantic proximity Read ↗

Synergistic targeted therapy for acute promyelocytic leukaemia: a model of translational research in human cancerSemantic proximity Read ↗

Arsenic trioxide promotes mitochondrial DNA mutation and cell apoptosis in primary APL cells and NB4 cell line.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.